{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T18:47:20Z","timestamp":1763318840417},"reference-count":19,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2019,11,30]]},"DOI":"10.1536\/ihj.19-201","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T17:13:09Z","timestamp":1573751589000},"page":"1328-1333","source":"Crossref","is-referenced-by-count":7,"title":["Different Effects of Pulmonary Vein Isolation on Quality of Life Between Patients with Persistent and Paroxysmal Atrial Fibrillation"],"prefix":"10.1536","volume":"60","author":[{"given":"Masaru","family":"Kato","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro","family":"Miake","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Ogura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Iitsuka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Okamura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tomomori","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Tsujimoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kato","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","volume":"118","year":"2008","unstructured":"1. Jais P, Cauchemez B, Macle L, <i>et al<\/i>. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008; 118: 2498-505.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Wilber DJ, Pappone C, Neuzil P, <i>et al<\/i>. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010; 303: 333-40.","DOI":"10.1001\/jama.2009.2029"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cosedis Nielsen J, Johannessen A, Raatikainen P, <i>et al<\/i>. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 2012; 367: 1587-95.","DOI":"10.1056\/NEJMoa1113566"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wazni OM, Marrouche NF, Martin DO, <i>et al<\/i>. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634-40.","DOI":"10.1001\/jama.293.21.2634"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Aliot E, Botto GL, Crijns HJ, <i>et al<\/i>. Quality of life in patients with atrial fibrillation: how to assess it and how to improve it. Europace 2014; 16: 787-96.","DOI":"10.1093\/europace\/eut369"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Takayama K, Hachiya H, Iesaka Y, <i>et al<\/i>. Early recurrence after longstanding persistent atrial fibrillation ablation time course, optimization of the blanking period, and clinical outcome. Int Heart J 2018; 59: 321-7.","DOI":"10.1536\/ihj.16-652"},{"key":"7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.hrthm.2011.12.016","volume":"9","year":"2012","unstructured":"7. Calkins H, Kuck KH, Cappato R, <i>et al<\/i>. 2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 2012; 9: 632-9.","journal-title":"Heart Rhythm","ISSN":"http:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kondo T, Miake J, Kato M, <i>et al<\/i>. Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation for persistent atrial fibrillation. J Cardiol 2016; 68: 229-35.","DOI":"10.1016\/j.jjcc.2015.09.012"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kinugasa Y, Kato M, Sugihara S, <i>et al<\/i>. A simple risk score to predict in-hospital death of elderly patients with acute decompensated heart failure: Hypoalbuminemia as an additional prognostic factor. Circ J 2009; 73: 2276-81.","DOI":"10.1253\/circj.CJ-09-0498"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Miyagi M, Kinugasa Y, Sota T, <i>et al<\/i>. Diaphragm muscle dysfunction in patients with heart failure. J Card Fail 2018; 24: 209-16.","DOI":"10.1016\/j.cardfail.2017.12.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bulkova V, Fiala M, Havranek S, <i>et al<\/i>. Improvement in quality of life after catheter ablation for paroxysmal versus long-standing persistent atrial fibrillation: A prospective study with 3-year follow-up. J Am Heart Assoc 2014; 3: e000881.","DOI":"10.1161\/JAHA.114.000881"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yagishita A, Yamauchi Y, Sato H, <i>et al<\/i>. Improvement in the quality of life and exercise performance in relation to the plasma B-type natriuretic peptide level after catheter ablation in patients with asymptomatic persistent atrial fibrillation. Circ J 2017; 81: 444-9.","DOI":"10.1253\/circj.CJ-16-1123"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mohanty S, Santangeli P, Mohanty P, <i>et al<\/i>. Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: Impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival. J Cardiovasc Electrophysiol 2014; 25: 1057-64.","DOI":"10.1111\/jce.12467"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Yamamoto K, Burnett JC Jr, Jougasaki M, <i>et al<\/i>. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-94.","DOI":"10.1161\/01.HYP.28.6.988"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Iwanaga Y, Nishi I, Furuichi S, <i>et al<\/i>. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47: 742-8.","DOI":"10.1016\/j.jacc.2005.11.030"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mollmann H, Weber M, Elsasser A, <i>et al<\/i>. NT-proBNP predicts rhythm stability after cardioversion of lone atrial fibrillation. Circ J 2008; 72: 921-5.","DOI":"10.1253\/circj.72.921"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Hussein AA, Saliba WI, Martin DO, <i>et al<\/i>. Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation. Circulation 2011; 123: 2077-82.","DOI":"10.1161\/CIRCULATIONAHA.110.007252"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lee SH, Jung JH, Choi SH, <i>et al<\/i>. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 2006; 70: 100-4.","DOI":"10.1253\/circj.70.100"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kodera S, Kiyosue A, Ando J, <i>et al<\/i>. Cost-effectiveness analysis of cardiovascular disease treatment in Japan. Int Heart J 2017; 58: 847-52.","DOI":"10.1536\/ihj.17-365"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/6\/60_19-201\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T07:09:52Z","timestamp":1575270592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/6\/60_19-201\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,30]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-201","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,30]]}}}